WINNERS & LOSERS: Asos sells Lichfield centre; CelLBxHealth revenue up
11th May 2026 11:24
(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Monday. Read More
| Price | 6.50p on 16-07-2026 at 16:30:01 |
|---|---|
| Change | -0.30p -4.41% |
| Buy | 7.00p |
| Sell | 6.00p |
| Last Trade: | Unknown 12,000.00 at 6.50p |
| Day's Volume: | 72,990 |
| Last Close: | 6.50p |
| Open: | 6.50p |
| ISIN: | GB00B02LCQ05 |
| Day's Range | 6.50p - 6.96p |
| 52wk Range: | 6.14p - 12.10p |
| Market Capitalisation: | £411.61m |
| VWAP: | 6.502129p |
| Shares in Issue: | 6.33b |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Allergy Thera. (AGY) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Unknown* | 12,000 | 6.50p | Uncrossing Trade |
16:35:20 - 16-Jul-26 |
| Sell* | 45,000 | 6.42p | Ordinary |
15:25:54 - 16-Jul-26 |
| Buy* | 10,000 | 6.60p | Suspected BUY Trade |
14:00:03 - 16-Jul-26 |
| Buy* | 5,990 | 6.96p | Suspected BUY Trade |
11:00:07 - 16-Jul-26 |
| Buy* | 14,000 | 6.80p | Suspected BUY Trade |
16:35:05 - 15-Jul-26 |
| Buy* | 276 | 7.00p | Ordinary |
15:54:34 - 15-Jul-26 |
| Buy* | 116 | 7.00p | SI Trade |
15:54:34 - 15-Jul-26 |
| Buy* | 5,000 | 6.80p | Suspected BUY Trade |
14:00:09 - 15-Jul-26 |
| Unknown* | 100,000 | 6.50p | Uncrossing Trade |
11:10:42 - 15-Jul-26 |
| Unknown* | 150,000 | 6.175p | Ordinary |
09:51:46 - 15-Jul-26 |
Allergy Thera. (AGY) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 30th Jun 2026 7:00 am | RNS | Vesting of Options under Long-Term Incentive Plan |
| 15th Jun 2026 7:00 am | RNS | Long Term Incentive Awards |
| 12th Jun 2026 7:00 am | RNS-R | Allergy Therapeutics to present at EAACI 2026 |
| 31st Mar 2026 7:00 am | RNS | Interim Results for six months ended 31 Dec 2025 |
| 12th Mar 2026 7:00 am | RNS | PDMR Dealings & Shareholding Update |
| 12th Mar 2026 7:00 am | RNS | PDMR Dealings & Shareholding Update |
| 4th Mar 2026 7:00 am | RNS | Positive Biomarker Results from PROTECT Trial |
| 26th Feb 2026 7:00 am | RNS-R | Allergy Therapeutics presents progress at AAAAI |
| 23rd Feb 2026 7:51 am | RNS | Update on funding and total voting rights |
| 30th Jan 2026 8:22 am | RNS | Chief Strategy Officer and Board appointments |